文献速递胸部CT

预测局部晚期非小细胞肺癌根治性放化疗后局部区域失败的影像组学列线图

Radiomics Nomogram for Predicting Locoregional Failure in Locally Advanced Non-small Cell Lung Cancer Treated with Definitive Chemoradiotherapy.
PubMed 文献 · Acad Radiol · 2020-12-08

本研究纳入2014年1月至2017年12月接受根治性放化疗的141例局部晚期非小细胞肺癌患者,分为测试队列(100例)和验证队列(41例),从治疗前增强CT提取影像组学特征构建列线图预测局部区域失败。影像组学列线图结合影像组学特征与临床预后因素,在测试队列和验证队列的C指数分别为0.796(95%CI:0.709-0.883)和0.756(95%CI:0.674-0.838),优于单独影像组学特征或临床预测因素。

要点

  • 影像组学列线图结合影像组学特征与临床因素,测试队列C指数0.796(95%CI:0.709-0.883),验证队列0.756(95%CI:0.674-0.838)。
  • 联合列线图对局部区域失败的预测性能优于单独影像组学特征(C指数0.776;95%CI:0.686-0.866)或临床预测因素(C指数0.641;95%CI:0.542-0.740),p < 0.001。
  • 影像组学特征由8个所选特征组成,是局部区域失败的独立因素;临床预测因素为组织学类型和临床分期。

核心结论

  • 影像组学列线图对局部晚期非小细胞肺癌患者的局部区域失败预测表现最佳,可能有助于优化个体化治疗。

研究设计与样本

  • 研究纳入2014年1月至2017年12月接受根治性放化疗的141例局部晚期非小细胞肺癌患者,分为测试队列(n=100)和验证队列(n=41)。
  • 从治疗前增强CT提取影像组学特征,采用最小绝对收缩和选择算子逻辑回归在测试队列中选择预测特征并构建影像组学特征。
  • 采用单变量和多变量Cox回归分析临床特征和影像组学特征,建立包含影像组学特征和独立临床因素的影像组学列线图。
  • 使用Harrell's C指数、校准曲线和决策曲线评估影像组学列线图的性能。

诊断标准与关键数值

  • 影像组学特征由8个所选特征组成,是局部区域失败的独立因素。
  • 局部区域失败的临床预测因素为组织学类型和临床分期。
  • 影像组学列线图在测试队列的C指数为0.796(95%CI:0.709-0.883),在验证队列为0.756(95%CI:0.674-0.838)。
  • 联合列线图预测局部区域失败的C指数为0.776(95%CI:0.686-0.866)的影像组学特征列线图与C指数为0.641(95%CI:0.542-0.740)的临床预测因素列线图相比,联合列线图性能更优(p < 0.001)。

临床应用与阅片要点

  • 影像组学列线图可能有助于优化局部晚期非小细胞肺癌患者的个体化治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To develop and validate a computed tomography (CT)-based radiomics nomogram for predicting locoregional failure (LRF) in patients with locally advanced non-small cell lung cancer (NSCLC) treated with definitive chemoradiotherapy (CRT).

MATERIALS AND METHODS: A total of 141 patients with locally advanced NSCLC treated with definitive CRT from January 2014 to December 2017 were included and divided into testing cohort (n = 100) and validation (n = 41) cohort. Radiomics features were extracted from pretreatment contrast enhanced CT. The least absolute shrinkage and selection operator logistic regression was processed to select predictive features from the testing cohort and constructed a radiomics signature. Clinical characteristics and the radiomics signature were analyzed using univariable and multivariate Cox regression. The radiomics nomogram was established with the radiomics signature and independent clinical factors. Harrell's C-index, calibration curves and decision curves were used to assess the performance of the radiomics nomogram.

RESULTS: The radiomics signature, which consisted of eight selected features, was an independent factor of LRF. The clinical predictors of LRF were the histologic type and clinical stage. The radiomics nomogram combined with the radiomics signature and clinical prognostic factors showed good performance with C-indexes of 0.796 (95% confidence interval [CI]: 0.709-0.883) and 0.756 (95% CI: 0.674-0.838) in the testing and validation cohorts respectively. Additionally, the combined nomogram resulted in better performance (p < 0.001) for the estimation of LRF than the nomograms with the radiomics signature (C-index: 0.776; 95% CI: 0.686-0.866) or clinical predictors (C-index: 0.641; 95% CI: 0.542-0.740) alone.

CONCLUSION: The radiomics nomogram provided the best performance for LRF prediction in patients with locally advanced NSCLC, which may help optimize individual treatments.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Chen X, Tong X, Qiu Q, et al. Radiomics Nomogram for Predicting Locoregional Failure in Locally Advanced Non-small Cell Lung Cancer Treated with Definitive Chemoradiotherapy. Acad Radiol. 2020. PMID: 33308945. doi:10.1016/j.acra.2020.11.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。